PROs Following Low-dose Irradiation for Osteoarthritis
PRO-LO
Patient Reported Outcomes Following Low-dose Irradiation for Osteoarthritis (PRO-LO): A Single-arm Prospective Registry
1 other identifier
observational
40
1 country
1
Brief Summary
The goal of this observational registry study is to collect data related to patient reported outcomes (pain, function, quality of life, toxicity) in osteoarthritis (OA) patients receiving standard of care radiation therapy (RT).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2023
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 20, 2023
CompletedFirst Posted
Study publicly available on registry
January 31, 2023
CompletedStudy Start
First participant enrolled
May 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2030
ExpectedJanuary 29, 2026
January 1, 2026
2.5 years
January 20, 2023
January 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Visual Analog Pain Scale (VAPS) Score from Baseline to M3 Post Radiation Treatment Completion
The investigators will use the visual analog 0-10 pain scale (VAPS) and compare the baseline pre-radiation measurement to that measured at 3 months post radiation.
Baseline and 3 months post RT
Secondary Outcomes (10)
Change in Visual Analog Pain Scale (VAPS) Score Over Time
Baseline up to 5 years post RT
Change in Hip Joint-Specific Outcome Over Time
Baseline up to 5 years post RT
Change in Knee Joint-Specific Outcome Over Time
Baseline up to 5 years post RT
Change in Arm, Shoulder and Hand Joint-Specific Outcome Over Time
Baseline up to 5 years post RT
Change in Foot Joint-Specific Outcome Over Time
Baseline up to 5 years post RT
- +5 more secondary outcomes
Study Arms (1)
Patients with osteoarthritis receiving radiation treatment
Patients with osteoarthritis receiving standard of care radiation treatment at UNC Radiation Oncology clinic. Radiation dose and fractionation prescription is at the physician's discretion. Typically, this prescription is delivered in 6 fractions, every other day, over 2 weeks.
Eligibility Criteria
Patients, aged 55 or above, who are receiving radiation treatment at UNC Radiation Oncology for Osteoarthritis are the intended study population.
You may qualify if:
- Willing and able to provide informed consent
- Established diagnosis of OA of at least 1 joint
- Inadequately controlled pain due to OA despite attempts with 2 or more other treatment modalities and Visual Analogue Pain Score of 4 or greater.
- Will undergo radiation as part of their standard of care for OA.
- At least 55 years old
- Ability to read and speak English.
You may not qualify if:
- Any woman who is pregnant or has reason to believe she is pregnant (the possibility of pregnancy has to be excluded by negative urine ß-HCG results, obtained within 2 weeks of CT simulation for radiation planning, or on the basis of patient history, e.g.: tubal ligation, hysterectomy or a minimum of 1 year without menses).
- Estimated life expectancy less than 6 months.
- Radiation treatment for shoulder OA
- Patient weight greater than 550lbs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UNC Chapel Hill
Chapel Hill, North Carolina, 27514, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Theodore Yanagihara, MD, PhD
University of North Carolina, Chapel Hill
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 20, 2023
First Posted
January 31, 2023
Study Start
May 31, 2023
Primary Completion
December 11, 2025
Study Completion (Estimated)
December 1, 2030
Last Updated
January 29, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share